What We Offer Real World Data at the Palm of Your Hands Our healthcare data integration services offer customers the ability to slice-and-dice through Data2Life’s Data-Lake. The Data-Lake is composed of an aggregated set of data streams such as (a) patient-generated data( gathered from online discussions forums and monitoring devices), (b) physician-generated data (electronic health/clinical records as well as pharma safety databases) and (c) topmost public spontaneous reporting systems data. Customers connecting to the open data API leverage the ability to achieve multi-dimensional analysis and enjoy “a richer analysis perspective”. Artificial Intelligence as-a-Service, on your BioPharma Data Artificial Intelligence (AI) value proposition to pharmas is simple: achieving operational efficiency (by freeing expensive resources from cumbersome tasks) and scaling data analytics processes without making any compromise on accuracy. Data2Life’s open-platform AI’s API offers customers the ability to run the company’s industry-leading AI algorithms on their own data. As of today, AI is being used by pharma and life-sciences industries in a constantly growing set of use-cases: case automation of lengthy mandatory processes, drug discovery’s hypothesis validation, extracting patient-voice using free-text analysis, etc. Optimizing Data Interactions and Maximizing Extracted Value Whether a company chooses to use our data or its own, whether it’s keen on leveraging our AI or not, “making sense of the data” remains a challenge. At Data2Life, not only we sell a data and analysis arsenal, our goal is to use our market and user mileage in order to help end-users to grasp the meaning of data, as well as to generate a user experience that will incline users to optimize their data interactions by enriching the depth and wealth of their data insights. Consulting Services Data2Life’s pharmacovigilance services are offered to customers looking for an in-depth understanding of the data landscape and how to assess real-world data sources, analytics and applications beyond the sheer drugs potential signals detection and analysis. This real world intelligence service focuses on analyzing and evaluating the potential benefits or risks of a medical product during various phases: early clinical trials (phases I,II,and III) as well as next phases. This allows PV specialists and medical affairs to make data-backed educated decisions.